- Home
- PLSE vs AMSF Comparison
PLSE vs AMSF Comparison
Compare PLSE & AMSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLSE
- AMSF
- Stock Information
- Founded
- PLSE 2014
- AMSF 1985
- Country
- PLSE United States
- AMSF United States
- Employees
- PLSE N/A
- AMSF N/A
- Industry
- PLSE Medical/Dental Instruments
- AMSF Accident &Health Insurance
- Sector
- PLSE Health Care
- AMSF Finance
- Exchange
- PLSE Nasdaq
- AMSF Nasdaq
- Market Cap
- PLSE 1.0B
- AMSF 968.5M
- IPO Year
- PLSE 2016
- AMSF 2005
- Fundamental
- Price
- PLSE $17.68
- AMSF $58.69
- Analyst Decision
- PLSE
- AMSF Buy
- Analyst Count
- PLSE 0
- AMSF 2
- Target Price
- PLSE N/A
- AMSF $59.50
- AVG Volume (30 Days)
- PLSE 195.0K
- AMSF 97.6K
- Earning Date
- PLSE 10-30-2024
- AMSF 10-23-2024
- Dividend Yield
- PLSE N/A
- AMSF 7.67%
- EPS Growth
- PLSE N/A
- AMSF N/A
- EPS
- PLSE N/A
- AMSF 3.21
- Revenue
- PLSE N/A
- AMSF $315,182,000.00
- Revenue This Year
- PLSE N/A
- AMSF N/A
- Revenue Next Year
- PLSE N/A
- AMSF $1.81
- P/E Ratio
- PLSE N/A
- AMSF $18.09
- Revenue Growth
- PLSE N/A
- AMSF 2.81
- 52 Week Low
- PLSE $6.60
- AMSF $41.97
- 52 Week High
- PLSE $22.69
- AMSF $60.24
- Technical
- Relative Strength Index (RSI)
- PLSE 52.89
- AMSF 66.65
- Support Level
- PLSE $15.62
- AMSF $57.10
- Resistance Level
- PLSE $17.20
- AMSF $58.94
- Average True Range (ATR)
- PLSE 1.27
- AMSF 1.23
- MACD
- PLSE -0.07
- AMSF -0.22
- Stochastic Oscillator
- PLSE 50.90
- AMSF 76.34
About PLSE Pulse Biosciences Inc (DE)
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.
About AMSF AMERISAFE Inc.
AMERISAFE Inc is a specialty provider of workers' compensation insurance to employers engaged in hazardous industries, mainly construction, trucking, manufacturing, oil and gas, and agriculture. The company generates a majority of its revenue in the form of premiums.